cropped-Website-Logo.png

Globela Pharma Pvt Ltd.

  • About
    • Journey and Achievements
    • Purpose and Approach
    • Globela Team and Events
  • Products & Services
  • Our Capabilities
  • Collaborate
  • Globela Group
  • Corp. Gov & Responsibility
  • Careers
  • Contact
    • Global/English
    • Spanish
    • French
    • Russian

Home

Yearly Archives: 2024

Generic Medicines

Generic Medicines: Importance, Challenges, and the Future of Affordable Healthcare

September 19, 2024
by Globela Globela Pharma

Generic medicines are essential in healthcare, offering affordable alternatives to brand-name drugs. They provide the same benefits as branded medications but at a much lower cost, making treatments more accessible, especially in lower and middle-income ...

Read More
Closing the Healthcare Gap

Closing the Healthcare Gap: Affordable Medicines for Lower and Middle-Income Countries

September 19, 2024
by Globela Globela Pharma

In lower and middle-income countries (LMICs), healthcare access is a significant challenge. The WHO reports that nearly two billion people globally struggle to access essential medicines, with about 80% of the world’s population living in countries with ...

Read More
3D render of a medical image with virus cells

Attacking Cancer Cells That Develop Resistance

July 1, 2024
by Globela Globela Pharma

Cancer remains one of the most intimating challenges in modern medicine, affecting millions of lives worldwide. While cancer treatment progress has been significant, resistance to therapies remains a serious challenge. Cancer cells often adapt and develo ...

Read More
WhatsApp Image 2024-06-17 at 18.40.16

Transforming Metastatic Breast Cancer Treatment: The Critical Role of Independent Research

June 24, 2024
by Globela Globela Pharma

Metastatic breast cancer (MBC) is a serious and complex form of cancer that continues to challenge researchers and clinicians. While there have been advancements in treating early-stage breast cancer, MBC remains difficult to manage and treat effecti ...

Read More
Revision. Two pharmacists making medicines revision in a drugstore

The Journey of a Drug: From R&D to Your Pharmacy Shelf

May 31, 2024
by Globela Globela Pharma

Every drug that reaches your pharmacy shelf undergoes a remarkable journey, traversing through various stages of research, development, manufacturing, and regulation. This journey is a testament to scientific innovation and a demonstration of stringent q ...

Read More
19476ec9-e0b2-45c5-8e57-2119e55f6f12

Green Chemistry: A Catalyst for Transformation in Pharma Manufacturing

May 15, 2024
by Globela Globela Pharma

Green chemistry, also known as sustainable chemistry, has emerged as a hope for industries striving to minimize their environmental footprint while maximizing efficiency and innovation. Despite pharmaceutical companies' significant economic contribution, ...

Read More
WhatsApp Image 2024-04-29 at 15.15.53

Understanding APIs, Intermediates, and Finished Dosage Forms: A Guide for Pharma Professionals

April 29, 2024
by Globela Globela Pharma

Introduction In the intricate landscape of pharmaceutical development and manufacturing, a fundamental understanding of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms is paramount for professionals in the field. ...

Read More
WhatsApp Image 2024-04-15 at 17.49.58

Innovations in Nephrology Care: Exploring the Latest Treatment Options

April 16, 2024
by Globela Globela Pharma

Introduction Nephrology emerged as the leading internal medicine subspecialty post-WWI. Kidneys are vital for bodily function, filter waste, regulate fluids and minerals, control blood pressure, and produce urine and erythropoietin. Moreover, indiv ...

Read More
WhatsApp Image 2024-02-29 at 18.43.52

Beyond the Virus- The Connection Between CVD and COVID-19 Complications

March 1, 2024
by Globela Globela Pharma

Introduction- The world witnessed a catastrophe in the form of the COVID-19 pandemic. As per statistical data, more than 702 million active Covid positive cases are present worldwide. Moreover, the world lost around 7 million to the deadly virus. The ...

Read More
WhatsApp Image 2024-02-16 at 18.39.50

Cephalosporins Today: Current Applications and Impact on Modern Medicine

February 16, 2024
by Globela Globela Pharma

Introduction: Welcome to a comprehensive exploration of Cephalosporins, a pivotal group of antibiotics derived from Cephalosporium. In this blog, we'll delve into their mechanism of action, examine the different generations, explore their diverse ...

Read More
  • Analgesic
  • Anthelmintic
  • Anti Allergic
  • Anti bacterial
  • Anti Cold
  • Anti Diabetics
  • Anti Malarial
  • Antifungal
  • Antipsychotic & CNS
  • Antispasmodics
  • ARV - Antiretroviral
  • Cardiovascular Drugs
  • Cephalosporins & Betalactam
  • Electrolytes
  • Erectile Dysfunction
  • Gastrology
  • Immunosuppressant
  • Laxative
  • Nephrology
  • Oncology
  • Steroidal Anti Inflammatory
  • Urology
  • Vitamins and Minerals
cropped-Website-Logo.png

Globela Pharma Pvt Ltd.

Globela Pharma, a EU GMP, WHO GMP, ISO Certified, MNC Accredited company, is a leading manufacturer of quality pharmaceutical products with in 50+ nations around the world with expertise in R&D and a passion for innovation aligned with the industry’s gold standards to ensure high quality products made affordable.

  • Plot No. 357&358 Road Number 3 Near Ginza Industries, GIDC, Sachin, Surat, Gujarat 394230

Quick Links

  • Globela Laboratories
  • Therapeutic Areas
  • R & D
  • Collaboration
  • CRAMS
  • API
  • Intermediates
  • Awards
  • Event Gallery
  • Worldwide Locations

Our Company

  • About
  • Our Capabilities
  • Globela Group
  • Case Studies
  • Blogs
  • Corp. Gov & Responsibility
  • Careers
  • Latest at Globela
  • Investor Relations

© 2022-23. All rights reserved.

Facebook Instagram Linkedin
Shopping Basket

WhatsApp us

Download DC Granules & Pellets List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested

Download Intermediates List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested

Download API List PDF

Enter your name and email to download PDF.

Name
Enter your email address

Thanks, I’m not interested